David M. Brown
Microsoft (United States)(US)Retina Consultants of Texas(US)
Publications by Year
Research Areas
Retinal Diseases and Treatments, Retinal Imaging and Analysis, Air Quality and Health Impacts, Retinal and Optic Conditions, Occupational and environmental lung diseases
Most-Cited Works
- → Ranibizumab for Neovascular Age-Related Macular Degeneration(2006)5,818 cited
- → Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration(2006)3,475 cited
- → Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration(2012)2,431 cited
- → Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study(2008)1,312 cited
- → Size-Dependent Proinflammatory Effects of Ultrafine Polystyrene Particles: A Role for Surface Area and Oxidative Stress in the Enhanced Activity of Ultrafines(2001)1,311 cited
- → Structural-functional relationships in diabetic nephropathy.(1984)1,210 cited